Purchase Order 75N95019P00079
Award Date 12/14/18
Potential Completion Date 12/16/19
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $311,084 firm fixed price delivery order contract to Illumina, Inc. for Illumina reagents and consumables. As the sole manufacturer of the sequencing instruments used by the agency, Illumina will provide sequencing supplies to support genomic research being conducted at the National Institute on Drug Abuse. No set-aside provision was applied to this award made to the...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $95,768.60 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide 12 units of its Infinium Global Diversity Array-8 v1.0 kit with 96 samples per unit and 1 unit with 48 samples to support the agency's biomedical research efforts. Performance will take place in San Diego through August 2024. No set aside...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $513,896.40 firm fixed price delivery order contract to Illumina, Inc. to provide sequencing and array-based genomic analysis solutions. Illumina, a for-profit manufacturer, will deliver a range of sequencing systems, reagents, consumables, and bioinformatics products to support the agency's research and diagnostic needs. This order is part of Illumina's existing Indefinite...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price definitive contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $902,702.86 contract has a completion date of November 12, 2018 and does not contain a set-aside designation. Illumina has provided a range of goods and services to support genomic sequencing and analysis for research and...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and consumables. The award, valued at $12,524.80, is for the delivery of Illumina sequencing systems and related products to support NIDA's research and diagnostics needs. This award is not associated with a set-aside program. Illumina has received multiple...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $250,675.20 award, with a completion date of March 8, 2018, is for the provision of sequencing systems, reagents, consumables, and associated services to support the agency's genomics research and diagnostics efforts. Illumina has...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The $292,500.00 contract is for the provision of Illumina sequencing systems, reagents, and associated products and services to support genomic sequencing and analysis. Illumina is an experienced provider of sequencing and genomic analysis technologies to federal agencies, having previously supported work at the NIH, Centers for...
- This is a $78,707.44 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract does not have a set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, is providing various sequencing systems, reagents, consumables, and other support services to NIDA under this award. Illumina has previously received...
- This firm fixed-price purchase order for $306,030.00 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Illumina, Inc. The contract is for the provision of a sequencing instrument required for high-output sequencing gene expression analysis, under the Major Program Code "SEQUENCING INSTRUMENT REQUIRED FOR HIGH-OUTPUT SEQUENCING GENE EXPRESSION ANALYSIS". The award has a completion date of December...
- This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $82,507.48 contract has no set-aside designation and does not appear to be associated with a larger contracting vehicle. Under this award, Illumina will provide NIDA with various sequencing systems, reagents, consumables, and related services to support genomic research and diagnostics....